Abstract

Twenty oral xerosis patients who visited us were treated by L-cysteine ethylester hydrochloride. The following conclusions were obtained.1) Ten out of the 20 patients had Sjogren's disease, and the other ten were xerostomia, diagnosed by parotid sialography, labial salivary gland biopsy, salivary gland scintigraphy, measurements of salivary secretion and immuno-serological examinations of the peripheral blood.2) Scores of both subjective and objective symptoms showed a decreasing trend after treatment. Improvement of each symptoms was greater in patients with xerostomia compared to Sjogren's disease patients.3) The amount of salivary secretion increased significantly after treatment.4) Two patients, whose clinical symptoms were relieved markedly, showed much improvement in salivary gland scintigraphy by comparing time-activity curves before and after administration. Both the maximum accumulation ratio and the maximum secretion ratio increased on the time-activity curve.5) The results of general hematology, serum biochemistry and immuno-serology did not change significantly before and after administration. However, the content of saliva-originated serum amylase in blood decreased in ten of eleven patients after treatment.6) The global improvement rate was markedly improved in 2 cases, improved in 5 cases, slightly improved in 9 cases and no change in 4 cases. The improvement rate over slightly improved was 90% in xerostomia, 70% in Sjogren's disease and 80% in the total cases.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.